Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR
- PMID: 23325741
- PMCID: PMC6807317
- DOI: 10.1002/jcla.21558
Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR
Abstract
Background: There is a growing need to develop rapid laboratory research methods to counter the menace of drug resistant tuberculosis (MDR-TB) cases worldwide especially in developing countries. The present study was undertaken to investigate the type and frequency of rpoB and katG mutations in rifampicin (RIF) and isoniazid (INH) resistant strains respectively of Mycobacterium tuberculosis (MTB) circulating in Northern India and to explore the utility of multiplex-allele-specific (MAS)-PCR assay for detection of drug-resistant MTB isolates in low resource set up.
Methods: Phenotypic and genotypic drug susceptibility testing (DST) was performed on 354 MTB isolates.
Results: Mutation in rpoB gene was found most frequently at codons 531, 526 and 516 (59.83%, 45.29% and 22.22%, respectively). Further, combinations of 2-3 point mutations were also observed in 19.66% of RIF-resistant MTB strains. The frequency of mutations in katG gene was found at codon 315 among 82.95% of the INH-resistant MTB isolates. MAS-PCR detected rpoB and katG mutations in phenotypically resistant isolates with sensitivities of 93% and 83% respectively.
Conclusion: MAS-PCR assays can be used for rapid detection of drug-resistant TB strains in routine diagnostic practice, enabling early administration of appropriate treatment regimens to the affected patients.
© 2012 Wiley Periodicals, Inc.
Figures
References
-
- RNTCP, Annual Status Report 2009. Available from: http://www.tbcindia.org (http://planningcommission.nic.in/reports/genrep/health/RNTCP_2011.pdf) Accessed on 2012 July 20.
-
- Centers for Disease Control and Prevention (CDC) . Trends in tuberculosis – United States, 2008. Morb Mortal Wkly Rep 2009;58:249–253. - PubMed
-
- WHO . Global Tuberculosis Control: Epidemiology, Strategy, Financing WHO Report 2009. Geneva: World Health Organization; 2009. (WHO /HTM/ TB/2009.411).
-
- Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc Lung Dis 1998;79:3–29. - PubMed
-
- Musser JM, Kapur V, Williams DL, Kreiswirth BN, van Soolingen D, van Embden JD. Characterization of the catalase‐peroxidase gene (katG) and inhA locus in isoniazid‐resistant and ‐susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: Restricted array of mutations associated with drug resistance. J Infect Dis 1996:173:196–202. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
